Highlights from the International Headache Congress 2021

VJNeurology are excited to bring you the latest updates from the International Headache Congress 2021. Learn more about the highlights…

Read More

Major pivotal study leads to FDA approval of the Vivistim Paired VNS System for treatment of upper limb impairments after chronic ischemic stroke

The results of the VNS-REHAB clinical trial demonstrated significant improvements in upper arm function after the application of vagus nerve…

Read More

ESOC 2021: Shaping the future of stroke management and care

An overview covering some of the exciting research and scientific advances presented at the 7th European Stroke Organisation Conference (ESOC…

Read More

Non-oral INP104 as an acute treatment for migraine

Despite an increase in the number of treatments available for migraine, there is still an unmet need for therapies with…

Read More

Therapeutic plasma exchange with albumin replacement to slow cognitive decline in Alzheimer’s disease

The results of the Phase III AMBAR trial were presented at the 2021 EAN meeting. Read on to learn more…

Read More

Top clinical trial updates from AAN 2021: stroke and headache

Highlights from AAN 2021 in headache and stroke! Learn more about the major clinical trials reported at this years’ meeting.

Read More

Top clinical trial updates from AAN 2021: MG, PD & ALS

Discover updates from major clinical trials in myasthenia gravis, Parkinson’s disease & ALS presented at AAN 2021!

Read More

Highlights from ACTRIMS Forum 2021

Read More
The content of VJNeurology is intended for healthcare professionals